Conmed amends revolver, increasing size and pushing out maturity

By Sara Rosenberg

New York, Nov. 30 - Conmed Corp. amended its credit facility, increasing the revolver to $250 million and extending the maturity to Nov. 30, 2015, according to a news release.

Pricing on the revolver is Libor plus 175 basis points with a 25 bps undrawn fee.

There is a $75 million accordion feature.

The term loans currently outstanding will remain in place.

J.P. Morgan Securities LLC and Bank of America acted as the lead banks on the revolver, with JPMorgan as the administrative agent.

Conmed is a Utica, N.Y.-based medical technology company specializing in medical devices for surgical and patient monitoring markets.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.